Johns Hopkins Diabetes GuideBrand Names

Treatment of Neuropathic Pain

Michael Polydefkis, M.D., M.H.S., Brian Pinto, Pharm.D.
Treatment of Neuropathic Pain is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

INDICATIONS

FDA

  • Pregabalin for painful diabetic polyneuropathy (DPN)
  • Duloxetine for painful DPN

NON-FDA APPROVED USES

  • Gabapentin most commonly used non-FDA approved medication for DPN [1].
  • Non FDA-approved DPN pain medications include antidepressants, opiates or opiate-like agents and anti-epileptic medications.
  • Antidepressants include tricyclic antidepressants (amitriptyline, nortriptyline) and selective serotonin and norepinephrine reuptake inhibitors (SNRIs: venlafaxine, duloxetine).
  • Antiepileptic medications include gabapentin, valproate, lamotrigine, carbamazepine, oxcarbazepine, phenytoin and lacrosamide
  • Opiate or opiate-derivative agents include oxycodone, morphine sulfate, hydromorphone, fentanyl and tramadol.
  • Other agents include topical agents lidocaine cream, lidoderm patches, capsaicin cream, neutriceuticals (Metanx, alpha-lipoic acid) and devices (spinal stimulators, transcutaneous electrical nerve stimulation).

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: September 4, 2013